Simon Schliffke - Concepedia

Author

Simon Schliffke

University Medical Center Hamburg-Eppendorf

Also Known As

S Schliffke, S. Schliffke, S., Schliffke, Schliffke, Simon, Simon Christian Schliffke, Simon Schliffke

Publications

805

Citations

H-Index

Concepts

All Affiliations

University Medical Center Hamburg-Eppendorf Universität Hamburg University Cancer Center Hamburg Martin Luther University Halle-Wittenberg Kinderkrebs-Zentrum Hamburg

About

Simon Schliffke is an author at University Medical Center Hamburg-Eppendorf specializing in medicine, tumor microenvironment, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	436
2	Cell Biology	3	3	212
3	Immunology	3	3	153
4	Health Sciences	1	1	49
5	Cellular Therapies	1	1	42

Simon Schliffke

Publications

749

Citations

H-Index

Page 1

	Year	Citations
Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells Yongming Ren, Min Young Lee, Simon Schliffke, Journal of Molecular and Cellular Cardiology Induced Pluripotent Stem CellCardiac ReprogrammingDevelopmental BiologyMedicineBmp-4-directed Cardiac Differentiation	2011	144
Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes Malte Mohme, Simon Schliffke, Cécile L. Maire, Clinical Cancer Research	2018	136
Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy Jere Paavola, Simon Schliffke, Sandro Rossetti, Journal of Molecular and Cellular Cardiology Cardiac MuscleCardiomyopathyHeart FailureCardiovascular DiseaseGenetics	2013	113
T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors Donjetë Simnica, Nuray Akyüz, Simon Schliffke, OncoImmunology Age-specific Tcr MetricsSolid TumorsT-regulatory CellImmunologyImmunoediting	2019	62
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker Nuray Akyüz, Anna Brandt, Alexander Stein, International Journal of Cancer T-regulatory CellImmunologyT-cell DiversificationPathologyAntigen Processing	2016	49
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma Malte Mohme, Cécile L. Maire, Ulf Geumann, Clinical Cancer Research Cell TherapyImmunologyImmunoeditingImmunotherapeuticsHigh-grade Gliomas	2020	42
SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2 Lisa von Wenserski, Christoph Schultheiß, Sarah Naomi Bolz, Leukemia	2020	39
Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape Malte Mohme, Cécile L. Maire, Simon Schliffke, Acta Neuropathologica Communications	2020	35
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial Elisabeth Schorb, Lisa Kristina Isbell, Andrea Kerkhoff, The Lancet Haematology	2024	34
High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias Donjetë Simnica, Simon Schliffke, Christoph Schultheiß, Frontiers in Immunology	2019	27

Page 1